Hendrik Fuchs

Laboratory Head, Research Director, Deputy Institute's Director

Charité Universitätsmedizin Berlin - Campus Virchow-Klinikum

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hendrik Fuchs serves as the Laboratory Head, Research Director, and Deputy Institute's Director at Charité Universitätsmedizin Berlin Campus Virchow-Klinikum, Germany. His research encompasses diverse areas including gene delivery, cancer therapeutics, and cost-effectiveness analyses in healthcare. Recent publications reflect his expertise in recombinant protein expression, inflammation modulation, and targeted toxin development.

Articles (12)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Matthias Schwenkglenks

University of Zurich

SWITZERLAND

View details

Agnieszka Galanty

Jagiellonian University Medical College

POLAND

View details

Dawid Wnuk

Assistant Professor

POLAND

View details

Matthias Hartlieb

GERMANY

View details

Eduardo Fernandez-Megia

Universidade de Santiago de Compostela

SPAIN

View details

Elżbieta Pękala

Jagiellonian University Medical College

POLAND

View details

Isis Tara Wolf

University of Freiburg

GERMANY

View details

Katarzyna Klaś

Jagiellonian University Medical College

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hendrik Fuchs

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Recombinant Expression of a Ready‐to‐Use EGF Variant Equipped With a Single Conjugation Site for Click‐Chemistry

Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany

Broadening the Scope of Sapofection: Cationic Peptide-Saponin Conjugates Improve Gene Delivery In Vitro and In Vivo

DT-13 attenuates inflammation by inhibiting NLRP3-inflammasome related genes in RAW264.7 macrophages

A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861.

DT-13 Mediates Ligand-Dependent Activation of PPARγ Response Elements In Vitro

Saponin Fraction CIL1 from Lysimachia ciliata L. Enhances the Effect of a Targeted Toxin on Cancer Cells

Enhanced cytotoxicity of a Pseudomonas Exotoxin A based immunotoxin against prostate cancer by addition of the endosomal escape enhancer SO1861.

Synergistic Cytotoxicity of a Toxin Targeting the Epidermal Growth Factor Receptor and the Glycosylated Triterpenoid SO1861 in Prostate Cancer.

Shape Matters: Highly Selective Antimicrobial Bottle Brush Copolymers via a One-Pot RAFT Polymerization Approach

Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. Toxins 2022, 14, 478

Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861

Collaborators (8)

Matthias Schwenkglenks

Agnieszka Galanty

Dawid Wnuk

Matthias Hartlieb

Eduardo Fernandez-Megia

Elżbieta Pękala

Isis Tara Wolf

Katarzyna Klaś

Make your next move.